130 related articles for article (PubMed ID: 23673143)
1. Low-grade and anaplastic oligodendrogliomas: differences in tumour microvascular permeability evaluated with dynamic contrast-enhanced magnetic resonance imaging.
Jia Z; Geng D; Liu Y; Chen X; Zhang J
J Clin Neurosci; 2013 Aug; 20(8):1110-3. PubMed ID: 23673143
[TBL] [Abstract][Full Text] [Related]
2. Microvascular permeability of brain astrocytoma with contrast-enhanced magnetic resonance imaging: correlation analysis with histopathologic grade.
Jia ZZ; Geng DY; Liu Y; Chen XR; Zhang J
Chin Med J (Engl); 2013; 126(10):1953-6. PubMed ID: 23673117
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V
J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging.
Jia Z; Geng D; Xie T; Zhang J; Liu Y
J Clin Neurosci; 2012 Jun; 19(6):820-3. PubMed ID: 22381582
[TBL] [Abstract][Full Text] [Related]
5. The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging.
Jia ZZ; Gu HM; Zhou XJ; Shi JL; Li MD; Zhou GF; Wu XH
Eur J Radiol; 2015 Sep; 84(9):1805-9. PubMed ID: 26066470
[TBL] [Abstract][Full Text] [Related]
6. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.
Jiang JS; Hua Y; Zhou XJ; Shen DD; Shi JL; Ge M; Geng QN; Jia ZZ
Acad Radiol; 2019 Sep; 26(9):1215-1221. PubMed ID: 30416002
[TBL] [Abstract][Full Text] [Related]
9. Oligodendrogliomas.
Reiche W; Grunwald I; Hermann K; Deinzer M; Reith W
Acta Radiol; 2002 Sep; 43(5):474-82. PubMed ID: 12423457
[TBL] [Abstract][Full Text] [Related]
10. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors.
Roberts HC; Roberts TP; Bollen AW; Ley S; Brasch RC; Dillon WP
Acad Radiol; 2001 May; 8(5):384-91. PubMed ID: 11345268
[TBL] [Abstract][Full Text] [Related]
11. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
[TBL] [Abstract][Full Text] [Related]
12. Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results.
Larsson C; Kleppestø M; Rasmussen I; Salo R; Vardal J; Brandal P; Bjørnerud A
J Magn Reson Imaging; 2013 Apr; 37(4):818-29. PubMed ID: 23086710
[TBL] [Abstract][Full Text] [Related]
13. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging.
Zhao M; Guo LL; Huang N; Wu Q; Zhou L; Zhao H; Zhang J; Fu K
Oncol Lett; 2017 Nov; 14(5):5418-5426. PubMed ID: 29113174
[TBL] [Abstract][Full Text] [Related]
15. [The value of DCE-MRI in predicting IDH gene mutation of high-grade gliomas].
Lu HT; Xing W; Zhang YW; Qin HP; Wu RH; Ding JL
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(39):3105-3109. PubMed ID: 31648456
[No Abstract] [Full Text] [Related]
16. Conventional and advanced (DTI/SWI) neuroimaging findings in pediatric oligodendroglioma.
Wagner MW; Poretti A; Huisman TA; Bosemani T
Childs Nerv Syst; 2015 Jun; 31(6):885-91. PubMed ID: 25813856
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of oligodendroglial and astrocytic tumors using imaging results: the added value of perfusion MR imaging.
Yoon HJ; Ahn KJ; Lee S; Jang JH; Choi HS; Jung SL; Kim BS; Jeun SS; Hong YK
Neuroradiology; 2017 Jul; 59(7):665-675. PubMed ID: 28550465
[TBL] [Abstract][Full Text] [Related]
18. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
[TBL] [Abstract][Full Text] [Related]
20. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
